INTRODUCTION
The SARS-CoV-2 (COVID-19) pandemic impacted around 472 million people and killed around 6.09 million patients (1). Although the virus is largely responsible for respiratory symptoms, a growing number of dermatological signs and symptoms of this illness have been identified. Several reports worldwide have identified a range of potential skin manifestations of SARS-CoV-2 (COVID-19) (2-8). However, the frequency of dermatological presentation (between 0.2% to 29%) and also the timing of skin manifestations are difficult to ascertain (9-11).
Here we have a case report of a young woman who initially presented with a generalized pruritic urticarial rash ranging from one to seven centimeters in diameter on the 6th of January 2022.